Koninklijke Philips Net Income 2010-2025 | PHG
- Koninklijke Philips net income for the quarter ending March 31, 2025 was $0.080B, a 111.22% decline year-over-year.
- Koninklijke Philips net income for the twelve months ending March 31, 2025 was $0.843B, a 357.52% decline year-over-year.
- Koninklijke Philips annual net income for 2024 was $-0.76B, a 50.62% increase from 2023.
- Koninklijke Philips annual net income for 2023 was $-0.504B, a 70.23% decline from 2022.
- Koninklijke Philips annual net income for 2022 was $-1.694B, a 143.15% decline from 2021.
Koninklijke Philips Annual Net Income (Millions of US $) |
|
---|---|
2024 | $-760 |
2023 | $-504 |
2022 | $-1,694 |
2021 | $3,927 |
2020 | $1,356 |
2019 | $1,307 |
2018 | $1,287 |
2017 | $1,873 |
2016 | $1,602 |
2015 | $716 |
2014 | $552 |
2013 | $1,553 |
2012 | $291 |
2011 | $-1,798 |
2010 | $1,928 |
2009 | $591 |
Koninklijke Philips Quarterly Net Income (Millions of US $) |
|
---|---|
2025-03-31 | $80 |
2024-09-30 | $199 |
2024-06-30 | $486 |
2023-06-30 | $79 |
2023-03-31 | $-714 |
2022-06-30 | $-23 |
2021-06-30 | $181 |
2020-06-30 | $229 |
2019-06-30 | $273 |
2018-06-30 | $1 |
2017-06-30 | $275 |
2016-12-31 | $680 |
2016-09-30 | $413 |
2016-06-30 | $475 |
2016-03-31 | $35 |
2015-12-31 | $-51 |
2015-09-30 | $355 |
2015-06-30 | $301 |
2015-03-31 | $112 |
2014-12-31 | $169 |
2014-09-30 | $-138 |
2014-06-30 | $332 |
2014-03-31 | $189 |
2013-12-31 | $553 |
2013-09-30 | $374 |
2013-06-30 | $414 |
2013-03-31 | $213 |
2012-12-31 | $-482 |
2012-09-30 | $221 |
2012-06-30 | $204 |
2012-03-31 | $326 |
2011-12-31 | $-212 |
2011-09-30 | $102 |
2011-06-30 | $-1,934 |
2011-03-31 | $198 |
2010-12-31 | $630 |
2010-09-30 | $676 |
2010-06-30 | $331 |
2010-03-31 | $277 |
2009-12-31 | $384 |
2009-09-30 | $254 |
2009-06-30 | $64 |
2009-03-31 | $-75 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $23.033B | $19.503B |
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $239.054B | 28.75 |
Boston Scientific (BSX) | United States | $154.291B | 38.63 |
Stryker (SYK) | United States | $149.710B | 31.30 |
EssilorLuxottica (ESLOY) | France | $128.407B | 0.00 |
Medtronic (MDT) | Ireland | $110.260B | 15.63 |
Lonza Group Ag (LZAGY) | Switzerland | $50.622B | 0.00 |
Haleon (HLN) | United Kingdom | $47.216B | 26.92 |
ResMed (RMD) | United States | $37.817B | 28.40 |
Agilent Technologies (A) | United States | $33.696B | 21.97 |
GE HealthCare Technologies (GEHC) | United States | $33.311B | 15.81 |
Terumo (TRUMY) | Japan | $27.198B | 35.33 |
Insulet (PODD) | United States | $21.551B | 84.59 |
Zimmer Biomet Holdings (ZBH) | United States | $18.358B | 11.79 |
Baxter (BAX) | United States | $15.708B | 11.73 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.095B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.558B | 22.82 |
Lantheus Holdings (LNTH) | United States | $5.573B | 14.06 |
Prestige Consumer Healthcare (PBH) | United States | $4.039B | 18.04 |
Perrigo (PRGO) | Ireland | $3.660B | 9.28 |
Haemonetics (HAE) | United States | $3.526B | 16.06 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.280B | 27.25 |
ICU Medical (ICUI) | United States | $3.251B | 23.97 |
GN Store Nord (GNNDY) | Denmark | $2.346B | 19.43 |
LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
QuidelOrtho (QDEL) | United States | $1.901B | 13.07 |
AtriCure (ATRC) | United States | $1.598B | 0.00 |
Acuren (TIC) | United States | $1.263B | 0.00 |
AdaptHealth (AHCO) | United States | $1.216B | 12.34 |
Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
Neogen (NEOG) | United States | $1.057B | 13.53 |
BioLife Solutions (BLFS) | United States | $1.015B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.003B | 12.82 |
Kestra Medical Technologies (KMTS) | United States | $0.908B | 0.00 |
InMode (INMD) | Israel | $0.898B | 9.05 |
CeriBell (CBLL) | United States | $0.698B | 0.00 |
Owens & Minor (OMI) | United States | $0.607B | 5.04 |
Evolus (EOLS) | United States | $0.587B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.578B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
Valneva SE (VALN) | France | $0.468B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.459B | 0.00 |
Surmodics (SRDX) | United States | $0.413B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.396B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.335B | 12.32 |
SNDL (SNDL) | Canada | $0.321B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
Cerus (CERS) | United States | $0.252B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
ZimVie (ZIMV) | United States | $0.250B | 11.34 |
Sanara MedTech (SMTI) | United States | $0.249B | 0.00 |
Quanterix (QTRX) | United States | $0.241B | 0.00 |
Brainsway (BWAY) | Israel | $0.233B | 61.65 |
Biote (BTMD) | United States | $0.227B | 6.37 |
Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.220B | 65.33 |
OraSure Technologies (OSUR) | United States | $0.215B | 0.00 |
Omeros (OMER) | United States | $0.205B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.181B | 14.71 |
High Tide (HITI) | Canada | $0.178B | 0.00 |
Organigram Global (OGI) | Canada | $0.177B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
Exagen (XGN) | United States | $0.144B | 0.00 |
Vireo Growth (VREOF) | United States | $0.138B | 0.00 |
FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
Jin Medical (ZJYL) | China | $0.108B | 0.00 |
Veru (VERU) | United States | $0.102B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
Fonar (FONR) | United States | $0.088B | 11.32 |
Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
MacroGenics (MGNX) | United States | $0.083B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.078B | 0.00 |
Cytosorbents (CTSO) | United States | $0.075B | 0.00 |
Zynex (ZYXI) | United States | $0.074B | 0.00 |
Apyx Medical (APYX) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.067B | 0.00 |
Agape ATP (ATPC) | $0.063B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.061B | 0.00 |
ImmuCell (ICCC) | United States | $0.055B | 0.00 |
Nephros (NEPH) | United States | $0.045B | 59.98 |
Modular Medical (MODD) | United States | $0.044B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 13.25 |
Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
Safety Shot (SHOT) | United States | $0.023B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.016B | 0.00 | |
Flora Growth (FLGC) | United States | $0.015B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
Senestech (SNES) | United States | $0.007B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |